TW
ABMD

TrinityPoint Wealth’s Abiomed Inc ABMD Stock Holding History

TrinityPoint Wealth’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-23,721
Closed -$5.83M – 300
2022
Q3 		$5.83M Buy
23,721
+28
+0.1% +$7.56K 1.33% 16
2022
Q2 		$5.86M Buy
23,693
+1,341
+6% +$362K 1.3% 18
2022
Q1 		$7.4M Sell
22,352
-192
-0.9% -$59.1K 1.34% 16
2021
Q4 		$8.1M Sell
22,544
-119
-0.5% -$40.2K 1.44% 11
2021
Q3 		$7.38M Buy
22,663
+488
+2% +$165K 1.41% 11
2021
Q2 		$6.92M Hold
22,175
– – 1.41% 12
2021
Q1 		$7.07M Hold
22,175
– – 1.65% 8
2020
Q4 		$7.56M Sell
22,175
-2,000
-8% -$553K 1.82% 8
2020
Q3 		$6.7M Hold
24,175
– – 1.86% 8
2020
Q2 		$5.84M Hold
24,175
– – 1.85% 8
2020
Q1 		$3.51M Hold
24,175
– – 1.39% 12
2019
Q4 		$4.12M Hold
24,175
– – 1.39% 13
2019
Q3 		$5.33M Hold
24,175
– – 1.86% 9
2019
Q2 		$6.67M Hold
24,175
– – 3.2% 6
2019
Q1 		$6.9M Buy
24,175
+6,792
+39% +$2.26M 3.39% 6
2018
Q4 		$5.65M Buy
+17,383
New +$6.04M 3.47% 6

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

TrinityPoint Wealth's ABMD Position: Q4 2022 in Review

TrinityPoint Wealth sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 23,721 shares — an estimated $5.83M sold.

TrinityPoint Wealth first reported a position in ABMD in Q4 2018 and held it in 16 quarters. The position peaked at $8.1M in Q4 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • TrinityPoint Wealth reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • TrinityPoint Wealth sold 23,721 Abiomed Inc shares in Q4 2022, an estimated $5.83M.
  • TrinityPoint Wealth first reported a position in Abiomed Inc in Q4 2018 and held it in 16 quarters.
  • TrinityPoint Wealth's Abiomed Inc position peaked at $8.1M in Q4 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on TrinityPoint Wealth's 13F filing for Q4 2022, filed 7 Feb 2023.